ELV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $439.95
Market Cap (MRQ) $95.08B
P/E (TTM) 18.7
EPS (TTM) $23.54
Revenue (TTM) $201.83B
Div Yield 1.6%
ROE (TTM) 11.6%
Debt/Equity (MRQ) 0.7
52W Range $275–$451

ELV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 1
Ex-date Split Type
June 1, 2005 2-for-1 Forward

About Elevance Health, Inc. Common Stock Company overview from Wikipedia

05 · wikidata

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.

Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing (BPO)/Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States.

History

Anthem

In 1946, Anthem began in Indianapolis, Indiana, as Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. The companies grew significantly, controlling 80% of the medical insurance market in Indiana by the 1970s.

In 1972, the two firms, then known as Blue Cross of Indiana and Blue Shield of Indiana, entered into a joint operating agreement.

In 1985, the two companies merged into Associated Insurance Companies, Inc,, later called, The Associated Group, a holding company, but usage of the name "Anthem" persisted. In 1989, the company purchased American General Insurance Co. for $150 million and in 1991, it acquired The Shelby Insurance Co., based in Shelby, Ohio, for $125 million. In 1989, The Associated Group founded Acordia, a brokerage that sold and serviced insurance and employee benefit programs.

In 1993, Acordia acquired American Business Insurance for $130 million and the Federal Kemper Insurance Company for $100 million. The Associated Group merged with Southeastern Mutual Insurance Company, the operator of Blue Cross and Blue Shield of Kentucky. In 1994, it sold Raffensperger, Hughes & Co., Inc., Indiana's largest investment bank, to National City Corp.

In 1995, The Associated Group acquired Community Mutual Insurance, a provider of Blue Cross and Blue Shield insurance plans in Ohio with over 1.9 million policy holders), then set up Anthem Blue Cross and Blue Shield. In 1996, The Associated Group changed its name to Anthem Insurance Company. In August 1997, Anthem acquired Blue Cross and Blue Shield of Connecticut. It also sold Acordia to management.

In 1999, Anthem acquired Blue Cross and Blue Shield of New Hampshire and Blue Cross and Blue Shield of Colorado and Nevada, using debt financing. The acquisitions made since 1996 added 850,000 policy holders. Among its customer base were 2.4 million PPO and 964,000 HMO enrollees.

In 2000, Anthem acquired Blue Cross Blue Shield of Maine. The Gramm-Leach-Bliley Act of 1999 made it possible for Anthem to undergo demutualization and become a public company via an initial public offering, which made it the fourth largest public managed health care company in the United States.

In 2002, Anthem acquired Trigon Healthcare of Virginia, a Blue Cross and Blue Shield plan, the largest insurer in Virginia, for $4.04 billion. Anthem Insurance Company reached 11.9 million members.

Blue Cross of California

Blue Cross of California was the predecessor of WellPoint Health Network Inc.

In 1982, Blue Cross of California was founded with the consolidation of Blue Cross of Northern California (established in 1936) and Blue Cross of Southern California (established in 1937).

In 1992, WellPoint was formed to operate Blue Cross of California's managed care business. In January 1993, Blue Cross of California spun off its managed care business into a publicly traded entity, WellPoint Health Networks Inc. Blue Cross of California retained an 80% interest and voting control.

In 1996, Blue Cross of California restructured to a for-profit corporation, designating WellPoint Health Networks Inc. as the parent organization. In April 1996, WellPoint completed its acquisition of Massachusetts Mutual Life Insurance Company's group life and health insurance subsidiaries for approximately $380 million, making it the second-largest publicly held managed health company in the U.S. with 4 million policyholders.

In March 1997, WellPoint acquired the group health and life businesses of John Hancock Financial for $86.7 million. With this acquisition, WellPoint expanded its presence into Michigan, Texas, and the mid-Atlantic, and gained a unit that concentrated on serving the needs of large employers.

In 2000, WellPoint acquired PrecisionRx, a mail service pharmacy fulfillment center in Texas. In March 2000, WellPoint acquired Rush Prudential Health Plans, a Chicago provider, for $204 million. In March 2001, WellPoint acquired Cerulean Companies, the parent company of Blue Cross Blue Shield of Georgia. In 2001, WellPoint offered to acquire CareFirst BlueCross BlueShield for $1.37 billion, including $119 million in bonuses to Carefirst executives. In 2003, the offer was rejected by the Maryland insurance commissioner.

In 2002, WellPoint acquired RightChoice Managed Care, a Missouri-based company that ran Blue Cross and Blue Shield for part of the state, for $1.5 billion. RightChoice also owned provider network company HealthLink. WellPoint also acquired MethodistCare of Houston, Texas and HealthLink. In 2003, WellPoint acquired Golden West Dental and Vision of Camarillo, California, and Cobalt, including Blue Cross and Blue Shield United of Wisconsin.

In November 2004, Wellpoint, Inc. was formed by the merger of Anthem Insurance Company and WellPoint Health Networks Inc. The merger was structured as Anthem acquiring WellPoint Health Networks and renaming itself WellPoint, Inc. WellPoint continued to use 'Anthem' as the brand name under which it operated. It sold its Blue Cross and Blue Shield products in 11 states.

In 2005, WellPoint acquired Alexandria, Virginia–based Lumenos, a provider of consumer-driven health care, for $185 million. Lumenos was the pioneer and market leader in consumer-driven health plans. In December, WellPoint acquired WellChoice, a New York City-based Blue Cross Blue Shield provider, for approximately $6.5 billion, making New York the 14th state in which WellPoint is a Blue Cross Blue Shield licensee.

In 2007, WellPoint acquired Chicago-based American Imaging Management, a radiology benefit management company that creates software to help physicians choose cost-effective locations for their patients to receive medical imaging tests. WellPoint also acquired Chicago-based American Imaging Management (AIM), the leading radiology benefit management company.

In January 2008, Leslie Margolin became the president of California operations. She resigned in July 2010. In 2008, WellPoint acquired Resolution Health, a firm that analyzes patient history for potential medical problems such as adverse drug interactions. In 2009, WellPoint acquired DeCare Dental, a dental insurance firm.

In 2011, WellPoint acquired CareMore, a Cerritos, California-based provider of insurance and care centers for elderly patients. In 2012, WellPoint acquired Amerigroup for $4.9 billion, anticipating significant growth due to Medicaid expansion under the Patient Protection and Affordable Care Act. In August 2012, CEO Angela Braly resigned due to pressure from investors.

On August 13, 2014, WellPoint announced it intended to change its name to Anthem, Inc., effective in December.

Anthem, Inc.

In February 2015, the company acquired Simply Healthcare Holdings, a Medicaid and Medicare managed care company based in Florida. In June 2015, Anthem made an offer to acquire Cigna for more than $54 billion in cash and stock. In February 2017, United States district court Judge Amy Berman Jackson blocked the Cigna merger on grounds of anti-competitive practices. On February 14, Cigna called off its merger agreement with Anthem.

In October 2017, Anthem announced that it would not renew its pharmacy benefit management (PBM) relationship with Express Scripts saying it had been overcharged $3 billion and that instead, Anthem would eventually handle the PBM process itself through its new IngenioRx unit. Anthem announced that it would enter a 5-year contract with CVS Health. Cigna then announced plans in March 2018 to acquire Express Scripts for $58 billion. On November 6, 2017, Gail Koziara Boudreaux was named CEO. In 2018, the company announced a $20 million expansion of its headquarters and the signing of a lease in Atlanta for its technology center. In March 2020, Anthem announced the acquisition of Beacon Health Options, and independently held behavioral health organization.

On February 2, 2021, Anthem announced the acquisition of InnovaCare Health's Puerto Rico subsidiaries including MMM Holdings, LLC ("MMM") and its Medicare Advantage (MA) plan MMM Healthcare, LLC as well as affiliated companies and Medicaid plan. In November 2021, Anthem announced the acquisition of Integra Managed Care in New York. The acquisition of the New York-based international health insurance company was completed on May 5, 2022.

On June 28, 2022, Anthem announced a change of its corporate name to Elevance Health, Inc. and also changed its stock ticker symbol from "ANTM" to "ELV".

Elevance Health

On January 23, 2023, Elevance announced that it entered a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana, increasing Elevance's footprint to 15 states and adding 1.9 million new members. In 2023, Elevance announced that it would rebrand its Amerigroup business as Wellpoint starting in 2024.

As of 2025, Elevance subsidiaries Carelon Behavioral Health and Anthem Blue Cross and Blue Shield are the subject of three lawsuits in New York and Connecticut alleging that they operate ghost networks.

Subsidiaries

Elevance Health includes the following subsidiaries:

Amerigroup

District of Columbia (Medicaid)

Georgia (Medicaid)

New Mexico (Medicare Advantage)

Anthem Blue Cross

California

Blue Cross of California Partnership Plan (Medicaid)

New York (upstate)

Anthem Blue Cross Blue Shield

Colorado

Connecticut

Georgia

Indiana (includes Medicaid)

Kentucky

Anthem Blue Cross and Blue Shield Medicaid

Maine

Missouri (excluding 30 counties in the Kansas City area)

Nevada

Anthem Blue Cross and Blue Shield Healthcare Solutions (Medicaid)

New Hampshire

New York (downstate)

HealthPlus (Medicaid)

Ohio

Virginia (excluding Alexandria City, Arlington County, Falls Church City, and parts of Fairfax County)

HealthKeepers (Medicaid)

Wisconsin

Carelon Behavioral Health

Carelon Behavioral Health of California

Carelon Behavioral Health of Kansas

Carelon Health of Pennsylvania

Carelon Global Solutions (Business Process Outsourcing/Shared Services)

Freedom Health

Florida

Golden West Dental & Vision

California

HealthSun

Florida

MMM

Puerto Rico

Optimum Healthcare

Florida

Simply Healthcare

Florida

UniCare

West Virginia

WellPoint

Arizona (Medicare Advantage)

Iowa (Medicaid and Medicare Advantage)

Maryland (Medicaid)

Massachusetts (government employees)

New Jersey (Medicaid and Medicare Advantage)

Tennessee (Medicaid and Medicare Advantage)

Texas (Medicaid and Medicare Advantage)

Washington (Medicaid and Medicare Advantage)

Joint ventures

Elevance Health operates joint ventures including:

Anthem | MaineHealth (with MaineHealth)

Maine

Blue Medicare Advantage (with Independence Blue Cross)

Pennsylvania

Colorado Community Health Alliance (with Centura Health, Physician Health Partners and Primary Physician Partners)

Colorado

Healthy Blue Kansas (with Blue Cross and Blue Shield of Kansas and Blue Cross and Blue Shield of Kansas City)

Kansas

Healthy Blue Louisiana (with Blue Cross Blue Shield of Louisiana)

Louisiana

Summit Community Care

Arkansas

Centers Plan for Healthy Living

New York, Florida

Quality of care

In 2011, in the category of "Meeting National Standards of Care," California's state patient advocacy office gave Anthem a rating of 2 out of 4 stars. In 2014, it received 3 out of 4 stars in the same category. In 2022, twenty-one of Elevance Health's affiliated Medicaid plans earned accreditation for health equity from the National Committee for Quality Assurance (NCQA).

Controversies

Charitable donations

In 2007, WellPoint pledged to spend $30 million over three years, through the company's charitable foundation, to help the uninsured. In March 2010, the Los Angeles Times reported that WellPoint's tax records and website showed that the company had given only $6.2 million by 2009. The company said that the foundation had indeed fulfilled its $30-million commitment by mid-2009, but refused to provide any financial details to support its claim.

2007 DMHC investigation

In 2007, the California Department of Managed Health Care (DMHC) investigated Anthem's policies for revoking (rescinding) health care insurance policies. The DMHC randomly selected 90 instances where Anthem canceled the insurance of policy holders who had been diagnosed with costly or life-threatening illnesses, to find how many of these cancellations were legal. The agency concluded that all these cancellations were illegal.

In July 2008, Anthem Blue Cross agreed to a settlement with the California Department of Managed Health Care; however in doing so, WellPoint did not officially admit liability. To resolve allegations of improper policy rescissions (cancellations), WellPoint paid $10 million and reinstated plans for 1,770 policy-holders who were affected by cancelled policies. The company also agreed to provide compensation for any medical debts incurred by these policy-holders.

2010 Reuters exposé

In April 2010, Reuters alleged that Wellpoint "using a computer algorithm, identified women recently diagnosed with breast cancer and then singled them out for cancellation of their policies." The software used immediately triggered fraud investigation for those recently diagnosed with the disease as the company searched for some pretext to drop their policies. Wellpoint argued that its algorithm was scanning for diagnostic codes for conditions that patients might have known about during the insurance application. The story not only caused considerable public outrage, but it also led Secretary of Health and Human Services, Kathleen Sebelius, and President Barack Obama, to call on WellPoint to end the practice.

In 2011, Anthem began cancelling policies of members who had been paying premiums with credit cards, sometimes without calling or emailing the member ahead of time.

Opposition to healthcare reform

In August 2009, Anthem, the largest for-profit insurer in California, contacted its employees and urged them to get involved to oppose healthcare reforms proposed during the Obama administration. Consumer Watchdog, a nonprofit watchdog organization in Santa Monica, asked California Attorney General Jerry Brown to investigate its claim that WellPoint had illegally pushed workers to write to their elected officials, attend town hall meetings and enlist family and friends to ensure an overhaul that would match the firm's interests. According to Consumer Watchdog, California's labor code directly prohibits coercive communications, including forbidding employers from controlling, coercing or influencing employees' political activities or affiliations. WellPoint had not been contacted by the California attorney general and had not seen any complaint.

Through 2010 and into 2011, WellPoint senior executives met monthly with executives of other major health insurers to blunt the effect of the Patient Protection and Affordable Care Act.

Premium increases in Maine

In 2009, Anthem Health Plans of Maine, a WellPoint subsidiary, sued the state of Maine for the right to increase premiums further. Since Maine licenses insurance companies through its Bureau of Insurance, Anthem needed the state's permission to raise rates. The Court disagreed with Anthem and found that, unlike with other forms of insurance, the Maine Insurance Code does not require the Superintendent to consider profits.

Rate increases in California

In February 2010, WellPoint announced that rates would increase on some Anthem Blue Cross individual policies in California by as high as 39%. The announcement resulted in an investigation by regulators from the Federal and California governments. Anthem Blue Cross gained worldwide media attention and became a poster child for the problem of rising cost of health care in the U.S. The rate increase came one year after Anthem had raised rates 68% on individual policy holders.

To explain the rate increases, some which were four times the rate of medical inflation, Anthem said the company had experienced a death spiral: the company claimed that with increased unemployment and declining wages, healthy customers dropped their insurance policies. Consequently, the remaining risk pool became sicker and thus more expensive to insure; and, in turn, prices were forced up and pushed more people out of the market.

In response to the outrage from politicians and consumers, Anthem postponed the rate increase until May 1, 2010.

Senator Dianne Feinstein of California proposed giving the Federal government of the United States authority to block insurance premium hikes that it considers to be "unjustified".

WellPoint cost reclassification

On March 17, 2010, WellPoint announced it was reclassifying some of its administrative costs as medical care costs in order to meet loss ratio requirements under the Patient Protection and Affordable Care Act, which requires insurers to spend at least 80% or 85% of customer premiums on health care services, depending on the type of plan.

2009–2010 data breach

In June 2010, Anthem sent letters to 230,000 customers in California warning them that their personal data might have been accessed online via a data breach. After a routine upgrade in October 2009, a third-party vendor stated that all security measures had been properly reinstated, when in fact they had not. As a result, personal information of thousands of coverage applicants who were under the age of 65 was exposed in the open. After a Los Angeles-area woman found that her application for coverage was publicly available, she filed a class action lawsuit against Anthem. While gathering evidence for the proceeding, the woman's lawyers downloaded some confidential customer information from Anthem's website and alerted Anthem about the breach. According to the lawyers, confidential information had remained exposed for five months. Greg Zoeller, Indiana's Attorney General, filed a lawsuit against the company seeking $300,000 in civil penalties for the company alleged failure to notify its consumers about the breach.

Denial of benefits for cancer treatment

In May 2014, Anthem Blue Cross refused to pay for the hospitalization of a Sonoma County, California man for stage four cancers, although he had paid Anthem over $100,000 in premiums. Anthem ended up paying for coverage following public outcry.

2015 data breach

On February 4, 2015, Anthem, Inc. disclosed that criminal hackers had broken into its servers and potentially stolen over 37.5 million records that contain personally identifiable information from its servers. According to Anthem, Inc., the data breach extended into multiple brands Anthem, Inc. uses to market its healthcare plans, including, Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross and Blue Shield, Amerigroup, Caremore, and UniCare. Healthlink was also victimized. Anthem says the medical information and financial data was not compromised. Anthem has offered free credit monitoring in the wake of the breach. According to Bloomberg News, China may be responsible for this data breach. Michael Daniel, chief adviser on cybersecurity for President Barack Obama, said he would be changing his own password. About 80 million company records were hacked, stoking fears that the stolen data could be used for identity theft. The compromised information contained names, birthdays, medical IDs, social security numbers, street addresses, e-mail addresses, employment information and income data. In June 2017, Anthem agreed to spend $115M to settle allegations that it failed to adequately protect the data of its clients, the sum was to be spent on two years of services to protect victims from identity theft. In 2019, two Chinese nationals were indicted for the breach.

"Avoidable ER program"

Beginning in 2015, Anthem has been implementing and expanding its "avoidable ER program" which means not reimbursing ER visits when the cause is not covered by the company. A few patients found out that they had been stuck with bills of over $10,000 that Anthem refused to reimburse. According to a 2013 report by the Journal of the American Medical Association, 87 percent of patients initially triaged as non-urgent ended up with a diagnosis that constituted an emergency. Critics derided the scheme, citing that it was unlawful by federal law to cover a person based on diagnosis, not symptoms. It was also considered unsafe, as it pressured patients to diagnose themselves before going to the ER.

Neglecting complaints

In 2017, the California Department of Managed Health Care fined the company $5 million for untimely response to consumer complaints. In 2019, this was settled at $2.8 million.

2019 lawsuit for coercive direct payments

In 2019, Sovereign Health pressed charges against Anthem, alleging that it was using direct payments to compel them to join Anthem's network under unfavorable terms. Sovereign owns facilities that treat people with addiction and mental health problems.

Diagnostics fraud

In March 2020, Anthem was sued by the Department of Justice. The lawsuit alleges that Anthem had submitted inaccurate diagnostics data in order to obtain increased Medicare reimbursements. In October 2022, a judge ordered Anthem to face the lawsuit.

Medicare Advantage star rating

In January 2024, Elevance Health filed a lawsuit with the Department of Health and Human Services (HHS) challenging changes in the Medicare Advantage star rating methodology. Star ratings are tied to key bonus payouts, and due to the new rating system in 2024 ratings have significantly decreased.

Finances

For the fiscal year 2017, Anthem reported earnings of US$3.843 billion, with an annual revenue of US$90.039 billion, an increase of 6.1% over the previous fiscal cycle. Anthem's shares traded at over $183 per share, and its market capitalization was valued at over US$69.1 billion in October 2018.

Recognition

The company was featured on the S&P Dow Jones Sustainability Index from 2018 to 2022, was named by Fortune as one of the 100 Best Companies to Work For, and was included on the Corporate Equality Index's list of Best Places to Work for LGBTQ Equality from 2015 to 2022.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

sectorHealth Care industryHealth Care employees96,129 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$199.12B
2016-12-31 → 2025-12-31
EPS$25.21
2016-12-31 → 2025-12-31
Free Cash Flow$3.17B
2016-12-31 → 2025-12-31
Net margin2.5%
2016-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend ELV 5Y avg Peer Median Verdict
P/E (TTM) 18.75Y avg ≈17.3 ≈17.3 36.3 Undervalued
P/S (TTM) 0.55Y avg ≈0.6 ≈0.6 0.7 Undervalued
P/B (MRQ) 2.15Y avg ≈2.6 ≈2.6 3.9 Undervalued
EV / EBITDA 13.75Y avg ≈12.8 ≈12.8 16.1 Undervalued
Price / FCF (TTM) 14.65Y avg ≈18.3 ≈18.3 · ·
Price / Cash Flow (TTM) 12.55Y avg ≈14.8 ≈14.8 15.6 Overvalued
EV / Revenue 0.65Y avg ≈0.7 ≈0.7 · ·
EV / FCF 37.75Y avg ≈22.2 ≈22.2 · ·
Price / Tangible Book (MRQ) 2.85Y avg ≈61.0 ≈61.0 · ·
PEG Ratio ≈2.7 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

13
Dividend Yield1.6%
Payout Ratio27.0%
Annualized Payout≈$6.88Paid quarterly
5Y Div CAGR≈12.5%Per share, split-adjusted
Growth Streak≈13Consecutive years of dividend growth
Ex-dateAmountCurrencyYield
Sep 10, 2026$1.72USD≈1.6%
Jun 10, 2026$1.72USD≈1.7%
Mar 10, 2026$1.72USD≈2.4%
Dec 5, 2025$1.71USD≈2.1%
Sep 10, 2025$1.71USD≈2.2%
Jun 10, 2025$1.71USD≈1.7%
Mar 10, 2025$1.71USD≈1.6%
Dec 5, 2024$1.63USD≈1.7%
Sep 10, 2024$1.63USD≈1.2%
Jun 10, 2024$1.63USD≈1.2%
Mar 7, 2024$1.63USD≈1.2%
Dec 5, 2023$1.48USD≈1.2%
Sep 7, 2023$1.48USD≈1.3%
Jun 8, 2023$1.48USD≈1.2%
Mar 9, 2023$1.48USD≈1.2%
Dec 2, 2022$1.28USD≈0.98%
Sep 8, 2022$1.28USD≈1.0%
Jun 9, 2022$1.28USD≈0.99%
Mar 9, 2022$1.28USD≈1.0%
Dec 2, 2021$1.13USD≈1.1%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 15.9%
PeriodReportEPS ActualEPS EstSurprise
Sept. 30, 2026 Oct 19, 2026 $6.99 $4.73 47.8%
June 30, 2026 Jul 15, 2026 $7.45 $6.27 18.9%
March 31, 2026 $12.58 $10.93 15.1%
Dec. 31, 2025 $3.33 $3.13 6.5%
Sept. 30, 2025 $6.03 $4.98 21.0%
June 30, 2025 $8.84 $9.04 -2.3%
March 31, 2025 $11.97 $11.50 4.1%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 13
Metric Trend 202520242023202220212020201920182017201620152014
Revenue $199.12B$177.01B$171.34B$156.59B$138.64B$121.87B$104.21B$92.11B$90.04B$84.86B$79.16B$73.87B
Cost of Revenue $21.18B$19.75B$17.29B$13.04B$10.89B$8.95B$1.99B$0$0···
SG&A Expense $20.98B$20.02B$20.09B$17.70B$15.92B$17.45B$13.36B$14.02B$12.65B$12.56B$12.53B$11.75B
Operating Income $7.20B$7.86B$8.50B$8.28B$7.56B$6.36B$6.00B$5.43B$4.17B$4.80B$4.75B$4.42B
Interest Expense ··$1.03B$851M$798M$784M$746M$753M$739M$723M$653M$601M
Pretax Income $6.71B$7.90B$7.71B$7.60B$8.00B$6.24B$5.99B$5.07B$3.96B$4.55B$4.63B$4.37B
Income Tax $1.05B$1.93B$1.72B$1.71B$1.85B$1.67B$1.18B$1.32B$121M$2.08B$2.07B$1.81B
Net Income $5.66B$5.98B$5.99B$5.89B$6.16B$4.57B$4.81B$3.75B$3.84B$2.47B$2.56B$2.57B
EPS (Basic) $25.28$25.81$25.38$24.56$25.26$18.23$18.81$14.53$14.70$9.39$9.73$9.31
EPS (Diluted) $25.21$25.68$25.22$24.28$24.95$17.98$18.47$14.19$14.35$9.21$9.38$8.99
Shares (Basic) 224,000,000231,700,000235,900,000240,000,000243,800,000250,800,000255,500,000258,100,000261,500,000262,900,000263,000,000275,900,000
Shares (Diluted) 224,600,000232,900,000237,400,000242,800,000246,800,000254,300,000260,300,000264,200,000267,800,000268,100,000272,900,000285,900,000
EBITDA $8.74B$9.26B$10.24B$10.13B$8.79B$7.51B$6.00B$5.43B$4.18B$4.80B$4.75B$4.42B
Balance Sheet 26
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents $9.49B$8.29B$6.53B$7.39B$4.88B$5.74B$4.94B$3.93B$3.61B$4.08B$2.11B$2.15B
Other Current Assets $5.34B$4.70B$5.79B$5.28B$4.65B$4.06B$3.02B$2.10B$2.25B$1.78B$1.56B$1.47B
Current Assets $63.00B$58.94B$60.03B$55.62B$51.12B$45.75B$39.03B$34.32B$36.26B$34.31B$30.86B$31.95B
PP&E (Net) $4.68B$4.65B$4.36B$4.32B$3.92B$3.48B$3.13B$2.73B$2.17B$1.98B$2.02B$1.94B
PP&E (Gross) $8.73B$8.33B$7.90B$7.12B$8.26B$7.33B$6.48B$5.55B$4.37B$4.14B$4.06B$3.76B
Accum. Depreciation $4.06B$3.68B$3.54B$2.80B$4.34B$3.84B$3.35B$2.81B$2.20B$2.16B$2.04B$1.82B
Goodwill $28.34B$28.28B$25.32B$24.38B$24.23B$21.69B$20.50B$20.50B$19.23B$17.56B$17.56B$17.08B
Intangibles $11.20B$12.09B$10.27B$10.31B$10.62B$9.40B$8.67B$9.01B$8.37B$7.96B$8.16B$7.96B
Other Non-current Assets $2.31B$2.14B$1.97B$1.69B$1.72B$1.44B$1.35B$758M$565M$468M$485M$512M
Total Assets $121.49B$116.89B$108.93B$102.75B$97.46B$86.61B$77.45B$71.57B$70.54B$65.08B$61.72B$61.68B
Accounts Payable $7.32B$6.93B$6.91B$5.61B$4.97B$5.49B$4.20B$4.96B$5.02B$4.01B$3.32B$3.65B
Short-term Debt $150M$365M$225M$265M$275M$0$700M$1.15B$1.27B$440M$540M$400M
Current Liabilities $41.03B$40.58B$41.79B$39.70B$34.88B$29.45B$23.53B$21.96B$23.36B$21.29B$19.09B$18.75B
Capital Leases $529M$658M$685M$751M$864M·······
Deferred Tax $2.11B$2.15B$1.97B$2.02B$2.81B$2.02B$2.23B$1.96B$1.73B$2.78B$2.63B$2.95B
Other Non-current Liabilities $3.53B$3.33B$1.74B$1.56B$1.68B$1.81B$1.42B$1.18B$925M$884M$994M$1.04B
Total Liabilities $77.47B$75.46B$69.52B$66.42B$61.29B$53.42B$45.73B$43.03B$44.04B$39.98B$38.67B$37.42B
Long-term Debt $31.90B$30.87B$24.89B$23.85B$22.76B$20.04B$19.39B$18.07B$18.66B$15.29B$15.32B$14.64B
Total Debt $32.05B$31.23B$25.12B$24.11B$23.03B$20.04B$20.09B$19.21B$19.93B$15.73B$15.86B$15.15B
Common Stock $2M$2M$2M$2M$2M$3M$3M$3M$3M$3M$3M$3M
Paid-in Capital $8.94B$8.91B$8.87B$9.08B$9.15B$9.24B$9.45B$9.54B$8.55B$8.81B$8.56B$10.06B
Retained Earnings $35.39B$33.55B$31.75B$29.65B$27.14B$23.80B$22.57B$19.99B$18.05B$16.56B$14.78B$14.01B
AOCI $-451M$-1.15B$-1.31B$-2.49B$-197M$150M$-296M$-986M$-101M$-268M$-293M$172M
Stockholders' Equity $43.88B$41.31B$39.31B$36.24B$36.09B$33.20B$31.73B$28.54B$26.50B$25.10B$23.05B$24.25B
Liabilities + Equity $121.49B$116.89B$108.93B$102.75B$97.46B$86.61B$77.45B$71.57B$70.54B$65.08B$61.72B$61.68B
Shares Outstanding 220,723,898227,479,695233,071,088237,958,067241,770,746245,401,430252,922,161257,395,577256,084,913263,747,395261,238,188268,109,932
Cash Flow 18
Metric Trend 202520242023202220212020201920182017201620152014
D&A $1.55B$1.39B$1.75B$1.68B$1.30B$1.15B$1.13B$1.13B····
Stock-based Comp $276M$191M$289M$264M$255M$283M$294M$226M$170M$165M$148M$169M
Deferred Tax $-279M$-374M$-602M$-115M$342M$-540M$81M$91M$-1.27B$127M$-66M$31M
Amort. of Intangibles $628M$580M$885M$767M$441M$361M$338M$358M$169M$192M$230M$221M
Other Non-cash $-2.92B$-1.38B$642M$511M$377M$5.22B······
Operating Cash Flow $4.29B$5.81B$8.06B$8.40B$8.36B$10.69B$6.06B$3.83B$4.18B$3.27B$4.21B$3.37B
CapEx $1.12B$1.26B$1.30B$1.15B$1.09B$1.02B$1.08B$1.21B$791M$584M$638M$715M
Investing Cash Flow $-1.34B$-5.17B$-5.57B$-4.56B$-9.64B$-7.32B$-2.79B$-1.26B$-5.08B$-514M$-1.15B$-975M
Debt Issued $2.99B$7.71B$2.57B$3.07B$3.46B$2.48B$2.47B$835M$5.46B$0$1.23B$2.70B
Net Debt Issued $844M$6.06B$665M$1.17B$2.39B$552M$1.35B$-849M$2.64B$0$-1.47B$970M
Stock Issued ·····$0$0$1.25B$0$0··
Stock Repurchased $2.60B$2.90B$2.68B$2.32B$1.90B$2.70B$1.70B$1.69B$2.00B$0$1.52B$3.00B
Net Stock Activity $-2.60B$-2.90B$-2.68B$-2.32B$-1.90B$-2.70B$-1.70B$-435M$-2.00B$0$-1.52B$-3.00B
Dividends Paid $1.53B$1.51B$1.40B$1.23B$1.10B$954M$818M$776M$705M$684M$657M$481M
Financing Cash Flow $-1.74B$1.19B$-3.35B$-1.32B$423M$-2.57B$-2.27B$-2.24B$427M$-799M$-3.09B$-1.82B
Net Change in Cash $1.20B$1.83B$-861M$2.51B$-861M$804M$1.00B$325M$-466M$1.96B$-38M$565M
Free Cash Flow $3.17B$4.55B$6.76B$7.25B$7.28B$9.67B$4.98B$2.62B$3.39B$2.62B$3.48B$2.65B
Levered FCF ··$5.97B$6.59B$6.66B$9.09B$4.38B$2.06B$2.67B$2.23B$3.12B$2.30B
Profitability 7
Metric Trend 202520242023202220212020201920182017201620152014
Operating Margin 3.6%4.4%5.0%5.4%5.4%5.2%5.8%5.9%4.6%5.7%6.0%6.0%
Net Margin 2.8%3.4%3.5%3.9%4.4%3.8%4.6%4.1%4.3%2.9%3.2%3.5%
Pretax Margin 3.4%4.5%4.5%5.0%5.7%5.1%5.7%5.5%4.4%5.4%5.9%5.9%
EBITDA Margin 4.4%5.2%6.0%6.5%6.3%6.2%5.8%5.9%4.6%5.7%6.0%6.0%
ROA 4.8%5.3%5.7%6.0%6.6%5.6%6.5%5.3%5.7%3.9%4.2%4.2%
ROE 13.3%14.8%15.8%16.7%17.0%13.6%15.2%13.0%14.6%9.9%11.1%10.6%
ROIC 8.0%8.2%10.2%10.8%9.8%8.8%9.3%8.4%8.7%6.4%6.8%6.6%
Liquidity & Solvency 5
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 1.51.51.41.41.51.61.71.61.61.61.61.7
Quick Ratio 0.20.20.20.20.10.20.20.20.20.20.10.1
Debt / Equity 0.70.80.60.70.60.60.60.70.80.60.70.6
LT Debt / Equity 0.70.70.60.60.60.60.60.60.70.60.70.6
Interest Coverage ··8.39.99.48.18.07.25.76.67.37.4
Efficiency 1
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 1.71.61.61.61.51.51.41.31.31.31.31.2
Per Share 6
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share $198.81$181.62$168.64$152.58$149.15$135.28$125.45$110.88$103.49$95.17$88.21$90.45
Revenue / Share $886.58$760.03$721.74$644.95$561.75$479.23$400.36$348.62$336.22$316.53$290.06$258.39
Cash Flow / Share $19.10$24.94$33.96$34.59$33.89$42.03$23.28$14.49$15.63$11.95$15.08$11.78
Cash / Share $43.00$36.43$28.00$31.04$20.18$23.39$19.52$15.28$14.09$15.45$8.09$8.03
Dividend / Share ··$5.92$5.12$4.52$3.80$3.20$3.00$2.70$2.60$2.50$1.75
EPS (TTM) $25.21$25.68$25.22$24.28$24.95$17.98$18.47$14.19$14.35$9.21$9.38$8.99
Growth Rates 10
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 12.5%3.3%9.4%13.0%13.8%·······
Revenue CAGR 3Y 8.3%8.5%12.0%·········
Revenue CAGR 5Y 10.3%···········
EPS YoY -1.8%1.8%3.9%-2.7%38.8%·······
EPS CAGR 3Y 1.3%0.97%11.9%·········
EPS CAGR 5Y 7.0%···········
Net Income YoY -5.3%-0.12%1.6%-4.3%34.7%·······
Net Income CAGR 3Y -1.3%-0.97%9.4%·········
Net Income CAGR 5Y 4.4%···········
Dividends Paid CAGR 5Y 9.9%···········
Valuation (TTM) 17
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM $199.12B$177.01B$171.34B$156.59B$138.64B$121.87B$104.21B$92.11B$90.04B$84.86B$79.16B$73.87B
Net Income TTM $5.66B$5.98B$5.99B$5.89B$6.16B$4.57B$4.81B$3.75B$3.84B$2.47B$2.56B$2.57B
Market Cap $77.37B$83.92B$109.91B$122.07B$112.07B$78.80B$76.39B$67.60B$57.62B$37.92B$36.43B$33.69B
Enterprise Value $99.93B$106.86B$128.50B$138.79B$130.22B$93.09B$91.54B$82.88B$73.94B$49.57B$50.18B$46.69B
P/E 13.914.418.721.118.617.916.418.515.715.614.914.0
P/S 0.40.50.60.80.80.60.70.70.60.40.50.5
P/B 1.82.02.83.43.12.42.42.42.21.51.61.4
P / Tangible Book 17.888.929.679.089.537.5······
P / Cash Flow 18.014.413.614.513.47.412.617.713.811.88.910.0
P / FCF 24.418.416.216.815.48.215.325.817.014.510.512.7
EV / EBITDA 11.411.512.513.714.812.415.315.317.710.310.610.6
EV / FCF 31.523.519.019.217.99.618.431.621.818.914.417.6
EV / Revenue 0.50.60.80.90.90.80.90.90.80.60.60.6
Dividend Yield 2.0%1.8%1.3%1.0%0.99%1.2%1.1%1.1%1.2%1.8%1.8%1.4%
Earnings Yield 7.2%7.0%5.3%4.7%5.4%5.6%6.1%5.4%6.4%6.4%6.7%7.1%
Payout Ratio 27.0%25.2%23.3%20.4%18.1%20.9%17.0%20.7%18.3%27.7%25.7%18.7%
Annual Payout $1.53B$1.51B$1.40B$1.23B$1.10B$954M$818M$776M$705M$684M$657M$481M

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $199.12B $177.01B $171.34B $156.59B $138.64B
Operating Margin % 3.6% 4.4% 5.0% 5.4% 5.4%
Net Income $5.66B $5.98B $5.99B $5.89B $6.16B
Diluted EPS $25.21 $25.68 $25.22 $24.28 $24.95

Institutional owners (13F) 1,775 filers · $82.1B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 1,775
Value held $82.1B
New positions 266
Exited positions 94
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
266 (+92 vs prior Q) 94 (-110 vs prior Q) 612 (+130 vs prior Q) 553 (-101 vs prior Q) +6.8M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $8,069,492,034 23,019,518 9.83% Shares
BlackRock, Inc. $7,344,424,106 18,991,090 8.95% Shares
VANGUARD CAPITAL MANAGEMENT LLC $5,436,729,233 14,058,204 6.63% Shares
STATE STREET CORP $4,032,282,885 10,426,610 4.91% Shares
WELLINGTON MANAGEMENT GROUP LLP $3,563,141,883 9,213,513 4.34% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $2,403,277,896 6,214,356 2.93% Shares
Sanders Capital, LLC $2,252,711,532 5,825,024 2.75% Shares
GEODE CAPITAL MANAGEMENT, LLC $1,990,239,599 5,166,124 2.43% Shares
HARRIS ASSOCIATES L P $1,904,455,957 4,924,511 2.32% Shares
Artisan Partners Limited Partnership $1,771,695,984 4,581,222 2.16% Shares
Invesco Ltd. $1,637,504,097 4,234,231 2.00% Shares
First Eagle Investment Management, LLC $1,619,701,186 4,188,196 1.97% Shares
NORGES BANK $1,531,008,381 3,958,856 1.87% Shares
Bank of New York Mellon Corp $1,246,348,719 3,222,787 1.52% Shares
FMR LLC $1,211,103,818 3,131,652 1.48% Shares
MORGAN STANLEY $1,007,728,234 2,605,764 1.23% Shares
NORTHERN TRUST CORP $817,928,536 2,114,986 1.00% Shares
CITIGROUP INC $810,919,703 2,096,863 0.99% Shares
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $779,725,026 2,016,200 0.95% Shares
GOLDMAN SACHS GROUP INC $775,630,749 2,005,613 0.95% Shares
Nuveen, LLC $769,539,548 1,989,863 0.94% Shares
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $749,415,810 1,935,880 0.91% Shares
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $737,324,542 2,518,615 0.90% Shares
BANK OF AMERICA CORP /DE/ $698,537,689 1,806,267 0.85% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $697,546,062 1,803,703 0.85% Shares
Legal & General Group Plc $688,469,125 1,780,232 0.84% Shares
Grantham, Mayo, Van Otterloo & Co. LLC $654,221,093 1,691,671 0.80% Shares
Amundi $635,991,799 1,644,537 0.78% Shares
DIMENSIONAL FUND ADVISORS LP $601,132,524 1,554,359 0.73% Shares
MANUFACTURERS LIFE INSURANCE COMPANY, THE $591,084,393 1,528,416 0.72% Shares
EAGLE CAPITAL MANAGEMENT LLC $576,772,638 1,491,409 0.70% Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $511,706,827 1,323,163 0.62% Shares
VANGUARD FIDUCIARY TRUST CO $461,498,831 1,193,336 0.56% Shares
BAILLIE GIFFORD & CO $418,920,245 1,083,237 0.51% Shares
JPMORGAN CHASE & CO $386,949,330 997,214 0.47% Shares
Ruane, Cunniff & Goldfarb L.P. $378,839,935 979,598 0.46% Shares
Brave Warrior Advisors, LLC $377,790,736 976,885 0.46% Shares
Newport Trust Company, LLC $369,294,278 954,915 0.45% Shares
DEUTSCHE BANK AG\ $364,707,273 943,054 0.44% Shares
FRANKLIN RESOURCES INC $360,834,432 933,040 0.44% Shares
1832 Asset Management L.P. $355,109,795 918,237 0.43% Shares
CITADEL ADVISORS LLC $350,526,658 906,386 0.43% Shares
Capital International Investors $290,732,899 751,772 0.35% Shares
UBS Group AG $286,115,618 739,833 0.35% Shares
ACR Alpine Capital Research, LLC $285,376,389 737,922 0.35% Shares
MILLENNIUM MANAGEMENT LLC $281,369,666 727,561 0.34% Shares
ROYAL BANK OF CANADA $268,753,000 694,935 0.33% Shares
High Ground Investment Management LLP $262,939,273 679,904 0.32% Shares
CANADA PENSION PLAN INVESTMENT BOARD $261,530,030 676,260 0.32% Shares
Qube Research & Technologies Ltd $247,577,198 640,181 0.30% Shares

Show all 1,775 institutional owners →

Company insiders 95 insiders · 57 officers · 37 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Gail Boudreaux President and CEO July 17, 2026 P 171,976 2 0 $1,002,230
Brian T Griffin EVP & CEO, IngenioRx May 3, 2018 M 15,863 0 0 $0
Angela F Braly Chair, President & CEO March 1, 2012 A 476,503 0 0 $0
Brian A Sassi President & CEO Cons, EVP June 7, 2011 S 60,825 0 0 $0
Dijuana K Lewis Pres & CEO CHS and EVP May 20, 2010 M 44,107 0 0 $0
Mark L Boxer Pres & CEO of OT&GS and EVP April 4, 2008 F 42,143 0 0 $0
Joan E Herman President & CEO Cons and EVP Dec. 7, 2007 S 30,369 0 0 $0
Mark Kaye EVP & CFO Oct. 22, 2026 S 19,919 0 13 $-4,658,357
John E Gallina EVP & Chief Financial Officer March 1, 2023 A 63,725 0 0 $0
Wayne S Deveydt EVP & Chief Financial Officer March 3, 2016 F 57,957 0 0 $0
David C Colby Vice Chairman, CFO & EVP April 4, 2007 F 343,071 0 0 $0
Thomas R Byrd President, Anthem Specialty Nov. 26, 2004 A 26,580 0 0 $0
Michael D Houk President, National Accounts Nov. 4, 2004 M 18,843 0 0 $0
John M Murphy President, Specialty Business May 17, 2004 A 20,806 0 0 $0
Caroline S Matthews Chief Operating Officer Dec. 1, 2004 A 40,471 0 0 $0
Erin M Wessling EVP & Chief Legal Officer Sept. 3, 2026 F 7,230 0 0 $0
Ryan R Craig EVP & Chief HR Officer Sept. 2, 2026 F 6,530 0 0 $0
Ronald W Penczek CAO & Controller June 12, 2026 S 3,740 0 2 $-765,958
Charles Morgan Kendrick JR EVP & President, Commercial March 6, 2026 S 11,791 0 1 $-910,604
Peter D Haytaian EVP & Pres Carelon & CarelonRx March 3, 2026 F 27,222 0 0 $0
Felicia F Norwood EVP &Chief Health Benefits Ofr March 2, 2026 A 38,838 0 0 $0
Ratnakar Lavu EVP & Chief Digital Info Ofr March 2, 2026 A 16,149 0 0 $0
Blair Williams Todt EVP, CLO & CAO Jan. 3, 2025 F 15,631 0 0 $0
Gloria M Mccarthy EVP & Chief Administrative Off March 24, 2023 S 51,435 0 0 $0
Leah Stark EVP & CHRO Dec. 30, 2021 F 12,403 0 0 $0
Jeffrey D. Alter EVP, IngenioRx & Anthem Health Oct. 1, 2021 F 5,107 0 0 $0
Patel Prakash R EVP & President, DBG Sept. 4, 2021 F 17,230 0 0 $0
Thomas C Zielinski EVP & General Counsel Nov. 3, 2020 M 17,910 0 0 $0
Craig E Samitt EVP & President, DBG July 26, 2018 M 17,274 0 0 $0
Joseph Swedish Executive Chairman March 5, 2018 S 61,419 0 0 $0
Jacquelyn H Wolf EVP & Chief HR Officer March 1, 2018 A 3,105 0 0 $0
Jose D. Tomas EVP & Chief HR Officer March 3, 2017 F 23,927 0 0 $0
Samuel R Nussbaum MD EVP & Chief Medical Officer May 19, 2015 M 110,973 0 0 $0
Martin B Silverstein EVP & Chief Strategy Officer May 1, 2015 F 23,249 0 0 $0
Kenneth R Goulet EVP, Commercial & Specialty March 2, 2015 A 84,281 0 0 $0
Richard C Zoretic EVP, Gov Business Division March 3, 2014 A 53,572 0 0 $0
John Cannon EVP, GC & Chief PAO Dec. 13, 2013 S 99,331 0 0 $0
Randal L Brown EVP & Chief HR Officer Sept. 4, 2013 M 30,332 0 0 $0
Lori A Beer EVP, Specialty Businesses & IT May 30, 2013 M 113,955 0 0 $0
Harlan A Levine EVP, CHS Aug. 31, 2012 S 25,244 0 0 $0
Venkata R Madabhushi EVP Sr Bus & Chf Transfrmn Off April 2, 2012 A 45,237 0 0 $0
Miller Martin SVP & Chief Accounting Officer March 1, 2011 A 29,329 0 0 $0
Fluegel M Bradley EVP, Chief Strategy Officer Nov. 5, 2010 M 52,634 0 0 $0
Cynthia S Miller EVP & Chief Actuary March 1, 2010 A 60,757 0 0 $0
Randall J Lewis EVP & Chief Compliance Officer Aug. 7, 2009 M 13,658 0 0 $0
Jamie S Miller SVP & Chief Accounting Officer March 3, 2008 A 25,710 0 0 $0
Alice F Rosenblatt EVP and Chief Actuary Jan. 22, 2008 S 39,265 0 0 $0
John S Watts JR EVP Dec. 7, 2007 S 108,311 0 0 $0
Marjorie W Dorr EVP May 22, 2007 M 38,951 0 0 $0
Michael A Stocker EVP Oct. 23, 2006 M 42,186 0 0 $0
Keith R Faller EVP Sept. 12, 2006 M 83,290 0 0 $0
David S Helwig EVP Aug. 18, 2006 M 55,055 0 0 $0
Thomas G Snead JR EVP Jan. 31, 2006 M 0 0 0 $0
Ronald J Ponder EVP Nov. 18, 2005 M 55,313 0 0 $0
David R Frick EVP May 12, 2005 S 58,241 0 0 $0
Michael L Smith EVP Feb. 18, 2005 S 98,810 0 0 $0
Jane E Niederberger Senior Vice President and Chie May 17, 2004 A 28,648 0 0 $0
Ramiro G Peru Director July 17, 2026 P 10,908 1 0 $366,050
Robert L Dixon JR Director June 11, 2026 S 10,734 0 1 $-60,667
Bahija Jallal Director May 13, 2026 A 5,351 0 0 $0
Antonio F Neri Director May 13, 2026 A 5,488 0 0 $0
Susan D. Devore Director May 13, 2026 A 4,065 0 0 $0
Amy Schulman Director May 13, 2026 A 781 0 1 $-7,475
Ryan M. Schneider Director May 13, 2026 A 7,163 0 0 $0
Deanna D Strable-Soethout Director May 13, 2026 A 2,209 0 0 $0
Steven H Collis Director May 13, 2026 A 4,202 1 0 $869,520
Lewis Hay III Director May 13, 2026 A 12,070 0 0 $0
Kerry R Clark Director May 14, 2025 A 9,640 0 0 $0
Elizebeth E Tallett Director May 15, 2024 A 10,291 0 0 $0
Julie A Hill Director May 20, 2021 S 31,213 0 0 $0
George A Schaefer JR Director May 16, 2018 A 38,864 0 0 $0
William J Ryan Director July 28, 2016 S 27,149 0 0 $0
John H Short Director May 14, 2014 A 2,981 0 0 $0
Warren Y Jobe Director March 13, 2014 G 26,525 0 0 $0
Lenox D Baker JR MD Director March 8, 2013 M 71,155 0 0 $0
Susan B Bayh Director May 21, 2012 S 0 0 0 $0
Sheila P Burke Director May 16, 2012 A 16,200 0 0 $0
Jackie M Ward Director May 16, 2012 A 23,806 0 0 $0
William H T Bush Director May 17, 2011 M 28,383 0 0 $0
William G Mays Director May 17, 2011 A 19,878 0 0 $0
Donald W Riegle JR Director May 16, 2011 M 3,894 0 0 $0
Jane G Pisano Director May 10, 2010 M 3,692 0 0 $0
Victor S Liss Director May 10, 2010 M 4,658 0 0 $0
Larry C Glasscock Director Feb. 25, 2010 M 3,352 0 0 $0
John Zuccotti Director May 20, 2009 A · 0 0 $0
Ben L Lytle Director May 10, 2005 A 2,128 0 0 $0
Leonard D Schaeffer Director May 10, 2005 A 1,041,024 0 0 $0
Allan B Hubbard Director Feb. 14, 2005 M 0 0 0 $0
John Sherman JR Director Dec. 1, 2004 M 4,164 0 0 $0
James W Mcdowell JR Director Oct. 1, 2004 A 1,271 0 0 $0
Dennis J Sullivan JR Director July 26, 2004 M 2,837 0 0 $0
Leeba Lessin · March 1, 2013 A 15,451 0 0 $0
Rebecca A Kapustay · April 1, 2005 M 34,557 0 0 $0
SANDERS ELIZABETH A · March 3, 2005 S 35,604 0 0 $0
William B Hart · Oct. 1, 2004 A 439 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 173 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IHF · iShares Trust 7.53% 237,106 SH Sept. 11, 2026 Daily
CVGD · Elevation Series Trust 3.56% 13,113 NS July 31, 2026 N-PORT
FDIV · EA Series Trust 1.95% 3,050 NS July 31, 2026 N-PORT
RPV · Invesco Exchange-Traded Fund Trust 1.72% 68,236 SH Oct. 23, 2026 Daily
RSPH · Invesco Exchange-Traded Fund Trust 1.70% 37,039 SH Oct. 23, 2026 Daily
BKDV · BNY Mellon ETF Trust II 1.65% 80,785 NS July 31, 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 1.64% 45,819 NS July 31, 2026 N-PORT
PWV · Invesco Exchange-Traded Fund Trust 1.62% 68,413 SH Oct. 23, 2026 Daily
IYH · iShares Trust 1.46% 127,077 SH Sept. 11, 2026 Daily
SRHQ · Elevation Series Trust 1.41% 7,981 NS July 31, 2026 N-PORT
IMCV · iShares Trust 1.22% 34,046 SH Sept. 11, 2026 Daily
VHT · VANGUARD WORLD FUND 1.22% 645,908 SH Aug. 19, 2026 Daily
FHLC · FIDELITY COVINGTON TRUST 1.19% 104,494 NS July 31, 2026 N-PORT
VMAX · Lattice Strategies Trust 1.18% 1,543 NS July 31, 2026 N-PORT
IXJ · iShares Trust 1.15% 114,143 SH Sept. 11, 2026 Daily
REVS · Columbia ETF Trust I 1.12% 9,954 NS July 31, 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 1.11% 257,140 SH Oct. 23, 2026 Daily
CURE · Direxion Shares ETF Trust 0.94% 4,273 NS July 31, 2026 N-PORT
NUDV · Nushares ETF Trust 0.92% 1,235 NS July 31, 2026 N-PORT
SYLD · Cambria ETF Trust 0.92% 24,249 NS July 31, 2026 N-PORT
ESMV · iShares Trust 0.91% 170 SH Sept. 11, 2026 Daily
EQIN · Columbia ETF Trust I 0.86% 6,959 NS July 31, 2026 N-PORT
ROUS · Lattice Strategies Trust 0.74% 13,856 NS July 31, 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0.73% 15,896 SH Aug. 19, 2026 Daily
RECS · Columbia ETF Trust I 0.73% 112,966 NS July 31, 2026 N-PORT
VLUE · iShares Trust 0.71% 163,004 SH Sept. 11, 2026 Daily
NULC · Nushares ETF Trust 0.69% 1,301 NS July 31, 2026 N-PORT
FBCV · FIDELITY COVINGTON TRUST 0.68% 3,202 NS July 31, 2026 N-PORT
FEUS · FlexShares Trust 0.61% 1,815 NS July 31, 2026 N-PORT
IMCB · iShares Trust 0.61% 24,486 SH Sept. 11, 2026 Daily
FDLO · FIDELITY COVINGTON TRUST 0.60% 22,637 NS July 31, 2026 N-PORT
IUS · Invesco Exchange-Traded Self-Indexe… 0.56% 12,793 SH Oct. 23, 2026 Daily
DIVB · iShares Trust 0.54% 26,159 SH Sept. 11, 2026 Daily
IDRV · iShares Trust 0.53% 143,110 SH Sept. 11, 2026 Daily
RDVI · First Trust Exchange-Traded Fund IV 0.52% 50,065 NS July 31, 2026 N-PORT
XOEF · iShares Trust 0.51% 273 SH Sept. 11, 2026 Daily
FTA · First Trust Exchange-Traded AlphaDE… 0.49% 18,161 NS July 31, 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0.47% 107,270 SH Oct. 23, 2026 Daily
BSCU · Invesco Exchange-Traded Self-Indexe… 0.47% 14,009,000 Oct. 23, 2026 Daily
BSCS · Invesco Exchange-Traded Self-Indexe… 0.45% 16,267,990 Oct. 23, 2026 Daily
SUSA · iShares Trust 0.45% 43,466 SH Sept. 11, 2026 Daily
ACWV · iShares, Inc. 0.44% 35,074 SH Sept. 11, 2026 Daily
ACVU · Hartford Funds Exchange-Traded Trust 0.42% 2,019 NS July 31, 2026 N-PORT
PALC · Pacer Funds Trust 0.42% 2,320 NS July 31, 2026 N-PORT
DEUS · DBX ETF Trust 0.41% 3,130 NS Aug. 31, 2026 N-PORT
EVUS · iShares Trust 0.40% 3,683 SH Sept. 11, 2026 Daily
MGV · VANGUARD WORLD FUND 0.39% 133,635 SH Aug. 19, 2026 Daily
CVY · Invesco Exchange-Traded Fund Trust 0.38% 1,030 SH Oct. 23, 2026 Daily
PFIG · Invesco Exchange-Traded Fund Trust … 0.38% 515,000 Oct. 23, 2026 Daily
DFUV · Dimensional ETF Trust 0.38% 154,644 NS July 31, 2026 N-PORT
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0.37% 8,210 NS July 31, 2026 N-PORT
QARP · DBX ETF Trust 0.37% 732 NS Aug. 31, 2026 N-PORT
BSCR · Invesco Exchange-Traded Self-Indexe… 0.37% 16,631,000 Oct. 23, 2026 Daily
USXF · iShares Trust 0.36% 12,883 SH Sept. 11, 2026 Daily
DFLV · Dimensional ETF Trust 0.36% 65,144 NS July 31, 2026 N-PORT
VIG · VANGUARD SPECIALIZED FUNDS 0.36% 1,200,113 SH Aug. 19, 2026 Daily
FHEQ · Fidelity Greenwood Street Trust 0.35% 8,603 NS July 31, 2026 N-PORT
VYM · VANGUARD WHITEHALL FUNDS 0.34% 847,792 SH Aug. 19, 2026 Daily
PFM · Invesco Exchange-Traded Fund Trust 0.34% 6,162 SH Oct. 23, 2026 Daily
IWX · iShares Trust 0.34% 31,304 SH Sept. 11, 2026 Daily
USMV · iShares Trust 0.32% 181,462 SH Sept. 11, 2026 Daily
DGRO · iShares Trust 0.31% 320,084 SH Sept. 11, 2026 Daily
VTV · VANGUARD INDEX FUNDS 0.31% 2,021,174 SH Aug. 19, 2026 Daily
IVE · iShares Trust 0.30% 360,968 SH Sept. 11, 2026 Daily
BSCT · Invesco Exchange-Traded Self-Indexe… 0.30% 9,595,000 Oct. 23, 2026 Daily
ACIO · ETF Series Solutions 0.29% 18,049 NS July 31, 2026 N-PORT
IUSV · iShares Trust 0.29% 189,556 SH Sept. 11, 2026 Daily
ADME · ETF Series Solutions 0.28% 2,222 NS July 31, 2026 N-PORT
HDUS · Lattice Strategies Trust 0.28% 1,531 NS July 31, 2026 N-PORT
ESG · FlexShares Trust 0.28% 990 NS July 31, 2026 N-PORT
VOOV · VANGUARD ADMIRAL FUNDS 0.28% 48,913 SH Aug. 19, 2026 Daily
SUSL · iShares Trust 0.26% 7,654 SH Sept. 11, 2026 Daily
FEX · First Trust Exchange-Traded AlphaDE… 0.26% 10,930 NS July 31, 2026 N-PORT
DSI · iShares Trust 0.26% 33,146 SH Sept. 11, 2026 Daily
ILCV · iShares Trust 0.25% 8,135 SH Sept. 11, 2026 Daily
SPXD · DBX ETF Trust 0.25% 45 NS Aug. 31, 2026 N-PORT
FAB · First Trust Exchange-Traded AlphaDE… 0.24% 1,096 NS July 31, 2026 N-PORT
USSG · DBX ETF Trust 0.24% 3,671 NS Aug. 31, 2026 N-PORT
IWD · iShares Trust 0.24% 482,434 SH Sept. 11, 2026 Daily
IQSU · New York Life Investments ETF Trust 0.24% 2,111 NS July 31, 2026 N-PORT
FBUF · Fidelity Greenwood Street Trust 0.24% 152 NS July 31, 2026 N-PORT
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0.23% 2,806 NS July 31, 2026 N-PORT
VONV · VANGUARD SCOTTSDALE FUNDS 0.23% 128,096 SH Aug. 19, 2026 Daily
RSP · Invesco Exchange-Traded Fund Trust 0.22% 494,598 SH Oct. 23, 2026 Daily
ESGG · FlexShares Trust 0.21% 627 NS July 31, 2026 N-PORT
EUSA · iShares, Inc. 0.21% 9,792 SH Sept. 11, 2026 Daily
SNPE · DBX ETF Trust 0.21% 15,613 NS Aug. 31, 2026 N-PORT
FYEE · Fidelity Greenwood Street Trust 0.21% 1,194 NS July 31, 2026 N-PORT
GLBL · Pacer Funds Trust 0.20% 6 NS July 31, 2026 N-PORT
AFLG · First Trust Exchange-Traded Fund VI… 0.20% 3,856 NS Aug. 31, 2026 N-PORT
ESGU · iShares Trust 0.19% 83,443 SH Sept. 11, 2026 Daily
SIZE · iShares Trust 0.19% 1,938 SH Sept. 11, 2026 Daily
QVML · Invesco Exchange-Traded Fund Trust … 0.17% 6,502 SH Oct. 23, 2026 Daily
USCL · iShares Trust 0.17% 11,477 SH Sept. 11, 2026 Daily
TOPC · iShares Trust 0.17% 133 SH Sept. 11, 2026 Daily
OMFL · Invesco Exchange-Traded Self-Indexe… 0.16% 17,547 SH Oct. 23, 2026 Daily
DFSU · Dimensional ETF Trust 0.16% 9,705 NS July 31, 2026 N-PORT
IWL · iShares Trust 0.16% 8,413 SH Sept. 11, 2026 Daily
XVV · iShares Trust 0.15% 2,493 SH Sept. 11, 2026 Daily
MGC · VANGUARD WORLD FUND 0.15% 42,364 SH Aug. 19, 2026 Daily
PBP · Invesco Exchange-Traded Fund Trust 0.15% 1,301 SH Oct. 23, 2026 Daily
PBUS · Invesco Exchange-Traded Fund Trust … 0.15% 34,893 SH Oct. 23, 2026 Daily
ESGV · VANGUARD WORLD FUND 0.14% 47,980 SH Aug. 19, 2026 Daily
IVV · iShares Trust 0.14% 2,737,349 SH Sept. 11, 2026 Daily
ACVF · ETF Opportunities Trust 0.14% 548 NS July 31, 2026 N-PORT
ILCB · iShares Trust 0.13% 4,087 SH Sept. 11, 2026 Daily
BKLC · BNY Mellon ETF Trust 0.13% 18,995 NS July 31, 2026 N-PORT
VOO · VANGUARD INDEX FUNDS 0.13% 5,589,584 SH Aug. 19, 2026 Daily
VV · VANGUARD INDEX FUNDS 0.13% 248,024 SH Aug. 19, 2026 Daily
IWB · iShares Trust 0.13% 150,486 SH Sept. 11, 2026 Daily
IYY · iShares Trust 0.13% 9,294 SH Sept. 11, 2026 Daily
PTLC · Pacer Funds Trust 0.13% 11,007 NS July 31, 2026 N-PORT
IWV · iShares Trust 0.12% 59,652 SH Sept. 11, 2026 Daily
ITOT · iShares Trust 0.12% 282,740 SH Sept. 11, 2026 Daily
PHDG · Invesco Actively Managed Exchange-T… 0.12% 171 SH Oct. 23, 2026 Daily
BBUS · J.P. Morgan Exchange-Traded Fund Tr… 0.12% 28,858 NS July 31, 2026 N-PORT
VOTE · TCW ETF Trust 0.12% 3,538 NS July 31, 2026 N-PORT
APUE · Trust for Professional Managers 0.12% 7,658 NS Aug. 31, 2026 N-PORT
VONE · VANGUARD SCOTTSDALE FUNDS 0.12% 35,020 SH Aug. 19, 2026 Daily
TOV · EA Series Trust 0.12% 873 NS July 31, 2026 N-PORT
DFUS · Dimensional ETF Trust 0.12% 65,434 NS July 31, 2026 N-PORT
DXUV · Dimensional ETF Trust 0.12% 1,719 NS July 31, 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0.12% 820 NS July 31, 2026 N-PORT
VOXP · Advisors Series Trust 0.12% 18 NS July 31, 2026 N-PORT
QDPL · Pacer Funds Trust 0.12% 5,228 NS July 31, 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0.11% 6,834,097 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.11% 17,880 SH Aug. 19, 2026 Daily
TOK · iShares Trust 0.11% 620 SH Sept. 11, 2026 Daily
DFAC · Dimensional ETF Trust 0.11% 134,751 NS July 31, 2026 N-PORT
TILT · FlexShares Trust 0.10% 6,004 NS July 31, 2026 N-PORT
HCMT · Direxion Shares ETF Trust 0.10% 1,508 NS July 31, 2026 N-PORT
URTH · iShares, Inc. 0.10% 19,735 SH Sept. 11, 2026 Daily
DCOR · Dimensional ETF Trust 0.10% 8,835 NS July 31, 2026 N-PORT
EQAL · Invesco Exchange-Traded Fund Trust … 0.10% 1,809 SH Oct. 23, 2026 Daily
KOKU · DBX ETF Trust 0.10% 2,013 NS Aug. 31, 2026 N-PORT
DFAU · Dimensional ETF Trust 0.10% 31,680 NS July 31, 2026 N-PORT
SPXL · Direxion Shares ETF Trust 0.09% 16,978 NS July 31, 2026 N-PORT
GLOF · iShares Trust 0.09% 455 SH Sept. 11, 2026 Daily
LGDX · Tidal Trust III 0.09% 342 NS July 31, 2026 N-PORT
ACWI · iShares Trust 0.09% 69,481 SH Sept. 11, 2026 Daily
CRBN · iShares Trust 0.08% 2,188 SH Sept. 11, 2026 Daily
NEAR · iShares U.S. ETF Trust 0.08% 3,886,000 SH Sept. 11, 2026 Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0.07% 290,778 SH Aug. 19, 2026 Daily
PICK · iShares, Inc. 0.06% 266,862 SH Sept. 11, 2026 Daily
DFVX · Dimensional ETF Trust 0.05% 720 NS July 31, 2026 N-PORT
LRGF · iShares Trust 0.03% 2,746 SH Sept. 11, 2026 Daily
VSS · VANGUARD INTERNATIONAL EQUITY INDEX… 0.03% 571,538 SH Aug. 19, 2026 Daily
SCZ · iShares Trust 0.03% 625,241 SH Sept. 11, 2026 Daily
PEVC · Pacer Funds Trust 0.02% 1 NS July 31, 2026 N-PORT
DYNF · BlackRock ETF Trust 0.01% 13,133 SH Sept. 11, 2026 Daily
IPAC · iShares Trust 0.01% 52,224 SH Sept. 11, 2026 Daily
VPL · VANGUARD INTERNATIONAL EQUITY INDEX… 0.01% 158,652 SH Aug. 19, 2026 Daily
WSML · iShares Trust 0.01% 9,378 SH Sept. 11, 2026 Daily
IEFA · iShares Trust 0.00% 1,291,652 SH Sept. 11, 2026 Daily
IDEV · iShares Trust 0.00% 211,325 SH Sept. 11, 2026 Daily
IXUS · iShares Trust 0.00% 168,378 SH Sept. 11, 2026 Daily
VXUS · VANGUARD STAR FUNDS 0.00% 2,181,735 SH Aug. 19, 2026 Daily
VEA · VANGUARD TAX-MANAGED FUNDS 0.00% 1,468,301 SH Aug. 19, 2026 Daily
VSGX · VANGUARD WORLD FUND 0.00% 30,111 SH Aug. 19, 2026 Daily
BIV · VANGUARD BOND INDEX FUNDS · · July 15, 2026 Daily
BLV · VANGUARD BOND INDEX FUNDS · · July 15, 2026 Daily
BSV · VANGUARD BOND INDEX FUNDS · · July 15, 2026 Daily
BND · VANGUARD BOND INDEX FUNDS · · July 15, 2026 Daily
VUSB · VANGUARD BOND INDEX FUNDS · · July 15, 2026 Daily
VCRB · VANGUARD MALVERN FUNDS · · July 15, 2026 Daily
VPLS · VANGUARD MALVERN FUNDS · · July 15, 2026 Daily
VSDB · VANGUARD MALVERN FUNDS · · July 15, 2026 Daily
VCSH · VANGUARD SCOTTSDALE FUNDS · · July 15, 2026 Daily
VCIT · VANGUARD SCOTTSDALE FUNDS · · July 15, 2026 Daily
VCLT · VANGUARD SCOTTSDALE FUNDS · · July 15, 2026 Daily
VTC · VANGUARD SCOTTSDALE FUNDS · · July 30, 2026 Daily
BNDW · VANGUARD SCOTTSDALE FUNDS · · July 30, 2026 Daily
VCEB · VANGUARD WORLD FUND · · July 30, 2026 Daily

ELV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 28 analysts BUY
Median target $485.00 +10.2%
7 25.0% Strong Buy
12 42.9% Buy
9 32.1% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

21 analysts · 2026-10-23

Mean target $479.62 +9.0%

Now Current price $439.95
Low$406.00 Mean$479.62 High$523.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
ELV $77.37B 13.9 12.5% 2.8% 13.3% ·
UNH $299.08B 25.0 11.8% 2.7% 12.0% ·
HUM $50.90B 26.0 10.1% 0.92% 7.0% ·
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9% ·
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
CLOV · -5.1 40.3% -4.5% -26.2% ·
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%
ALHC $4.03B · 46.1% -0.02% -0.52% ·

Latest News Recent headlines mentioning this company

23

Trading Signals Recent buy/sell signals with entry price and risk/reward ratio

25

No open signal right now — no card is filled, and that's honest.

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Oct 21, 2026